![CMS Clarifies Rules for IDTF Medicare Billing of Diagnostic Tests](https://www.g2intelligence.com/wp-content/uploads/2023/03/April23.NLR_.IDTF-iStock-1800x1250-1-1080x675.jpg)
CMS Clarifies Rules for IDTF Medicare Billing of Diagnostic Tests
The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.
The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.
Recent OIG report says Medicare could have saved up to $215.8 million on at-risk payments for G0483 definitive drug tests.
CMS recently proposed a rule that would make the False Claims Act rule the standard for overpayments under the Affordable Care Act regulations.
Here’s a quick briefing of the new codes that come into effect on April 1 that your billing staff should know about.
The rules unfairly favor insurers in out-of-network payment disputes, court says.
Though not yet recommended for screening by the ACS or other medical groups, recently developed blood-based tests show promise.
Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.
Labs may be billing Medicare for high-reimbursing and medically unnecessary drug tests, according to the OIG.
Though the e-commerce giant recently closed its acquisition of One Medical, FTC antitrust intervention could disrupt Amazon’s plans.
Though labs were again absent from recent key enforcement actions, sentences were handed down in other healthcare-related cases.